Health Canada approves Celltrion’s Steqeyma®, a biosimilar to Stelara® (ustekinumab) for the treatment of multiple chronic inflammatory conditions

View Full Size 

Download

• Full Size JPEG, 1684x548, 119.0 KB
• Small JPEG, 480x156, 32.5 KB
• Preview JPEG, 144x47, 7.0 KB
• Thumbnail JPEG, 120x39, 5.3 KB